Consolidated Statement Of Comprehensive Income

JCR Pharmaceuticals Co.,Ltd. - Filing #7604217

Concept 2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
Consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
14,446,000,000 JPY
14,446,000,000 JPY
14,446,000,000 JPY
14,517,000,000 JPY
14,446,000,000 JPY
7,081,000,000 JPY
7,081,000,000 JPY
6,888,000,000 JPY
7,081,000,000 JPY
7,081,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-71,000,000 JPY
107,000,000 JPY
Deferred gains or losses on hedges
0 JPY
0 JPY
Foreign currency translation adjustment
68,000,000 JPY
-162,000,000 JPY
Remeasurements of defined benefit plans, net of tax
0 JPY
7,000,000 JPY
Other comprehensive income
-3,000,000 JPY
-47,000,000 JPY
Comprehensive income
14,514,000,000 JPY
6,841,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
14,483,000,000 JPY
6,855,000,000 JPY
Comprehensive income attributable to non-controlling interests
31,000,000 JPY
-14,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.